NSG527 Final Exam Prep Document | 2026/2027 Edition | 250
Verified Questions
NSG527 Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation resource for NSG527 covers psychopathology, theories, and
advanced clinical modalities. It includes 250 verified questions and answers designed to help students
master key concepts and achieve a high score. The content is aligned with the latest Wilkes University
curriculum and evidence-based practices.
Key Features:
Psychopathology across the lifespan
Major theoretical frameworks (psychodynamic, cognitive-behavioral, humanistic, biological)
Advanced clinical modalities (CBT, DBT, EMDR, psychopharmacology)
Diagnostic criteria and differential diagnosis (DSM-5-TR)
Ethical and legal considerations in advanced practice
Integrated case studies and clinical reasoning
Updates for 2026:
- Updated to reflect DSM-5-TR diagnostic criteria
- Incorporated latest evidence-based treatment guidelines
- Added new questions on telehealth and cultural competence
- Revised rationales for clarity and accuracy
- Enhanced distractor explanations to address common misconceptions
Abstract:
This document provides a rigorous review of psychopathology, theoretical foundations, and advanced clinical
modalities essential for the NSG527 final exam. It synthesizes key concepts from major theoretical orientations,
including psychodynamic, cognitive-behavioral, humanistic, and biological perspectives, and applies them to the
assessment and treatment of mental disorders across the lifespan. The 250 verified questions are organized by
content area, with detailed rationales and distractor analyses to reinforce learning. Emphasis is placed on
differential diagnosis using DSM-5-TR criteria, evidence-based interventions, and ethical decision-making in
advanced practice nursing. This resource is designed to facilitate mastery of complex material and promote critical
thinking for clinical application.
Keywords:
NSG527, Psychopathology, Theories, Clinical Modalities, DSM-5-TR, Advanced Practice Nursing, Wilkes
University, Exam Prep
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining why it is correct. Incorrect
options are accompanied by distractor explanations that clarify common errors and reinforce key concepts.
Compliance Checklist:
Aligned with Wilkes University NSG527 curriculum
Based on DSM-5-TR diagnostic criteria
Incorporates current evidence-based practice guidelines
Includes ethical and legal standards for advanced practice
Covers lifespan and cultural considerations
Page 1
, Verified for accuracy by subject matter experts
Content Area Overview:
Content Area Questions Key Topics Weight
Foundations of Psychopathology 1-50 Historical perspectives, classification 20%
systems, epidemiology, etiology
Theoretical Frameworks 51-100 Psychodynamic, cognitive-behavioral, 20%
humanistic, biological, systems theory
Assessment and Diagnosis 101-150 Clinical interview, mental status exam, 20%
DSM-5-TR criteria, differential diagnosis
Advanced Clinical Modalities 151-200 CBT, DBT, EMDR, psychopharmacology, 20%
motivational interviewing
Special Populations and Ethical 201-250 Child/adolescent, geriatric, cultural 20%
Issues competence, legal/ethical dilemmas
Page 2
,Q1. A 34-year-old individual presents with a 6-month history of pervasive and excessive worry about
multiple life circumstances, accompanied by restlessness, muscle tension, sleep disturbance, and difficulty
concentrating. The individual reports that these symptoms have been present almost daily and are not
attributable to a substance or medical condition. Which of the following best describes the neurobiological
mechanism most implicated in the maintenance of this condition?
A. Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis leading to elevated cortisol and reduced
hippocampal volume
B. Dysregulation of the default mode network (DMN) with excessive connectivity between the prefrontal
cortex and amygdala
C. Impaired extinction of conditioned fear responses due to deficient ventromedial prefrontal cortex (vmPFC)
inhibition of the amygdala
D. Reduced gamma-aminobutyric acid (GABA)ergic tone in the basolateral amygdala and impaired
benzodiazepine receptor sensitivity
Correct Answer: D. Reduced gamma-aminobutyric acid (GABA)ergic tone in the basolateral amygdala and
impaired benzodiazepine receptor sensitivity
Rationale: Generalized anxiety disorder (GAD) is associated with reduced GABAergic inhibition in the amygdala
and other limbic structures, leading to heightened arousal and worry. Option A describes HPA axis hyperactivity
more characteristic of major depressive disorder. Option B describes DMN dysregulation seen in rumination but
not specific to GAD. Option C describes impaired fear extinction typical of PTSD, not the persistent worry of GAD.
Why Wrong:
A - HPA axis hyperactivity with elevated cortisol and hippocampal volume reduction is more characteristic of
major depressive disorder rather than generalized anxiety disorder.
B - Default mode network dysregulation is implicated in rumination and depression, not specifically in the
excessive worry of GAD.
C - Impaired fear extinction due to vmPFC-amygdala dysfunction is a hallmark of PTSD, not generalized
anxiety disorder.
Reference: Stahl, S. M. (2021). Stahl's Essential Psychopharmacology (5th ed.). Cambridge University Press, Ch.
8.
Q2. A patient with a history of recurrent major depressive episodes has not responded to adequate trials of
two different SSRIs and one SNRI. The patient is now being considered for augmentation with a
second-generation antipsychotic. Which of the following mechanisms best explains the efficacy of
aripiprazole in treatment-resistant depression?
A. Selective antagonism of 5-HT2A receptors leading to increased dopamine release in the prefrontal cortex
B. Partial agonism at D2 and 5-HT1A receptors combined with antagonism at 5-HT2A receptors
C. Potent inhibition of serotonin and norepinephrine reuptake with additional 5-HT2C antagonism
D. Full agonism at D1 receptors in the mesolimbic pathway enhancing reward processing
Correct Answer: B. Partial agonism at D2 and 5-HT1A receptors combined with antagonism at 5-HT2A
receptors
Rationale: Aripiprazole is a partial agonist at D2 and 5-HT1A receptors and an antagonist at 5-HT2A receptors.
This unique profile allows it to modulate dopaminergic and serotonergic transmission, improving depressive
symptoms without full blockade. Option A describes the mechanism of atypical antipsychotics like risperidone but
not aripiprazole. Option C describes the mechanism of vortioxetine, not aripiprazole. Option D is incorrect because
aripiprazole is not a full D1 agonist.
Why Wrong:
A - Selective 5-HT2A antagonism with increased prefrontal dopamine is characteristic of drugs like
risperidone, not aripiprazole.
C - Potent inhibition of serotonin and norepinephrine reuptake with 5-HT2C antagonism describes
vortioxetine, not aripiprazole.
D - Full D1 agonism is not a property of aripiprazole; it is a partial agonist at D2 receptors.
Page 3
, Reference: Lehne, R. A., & Rosenthal, L. (2022). Pharmacology for Nursing Care (11th ed.). Elsevier, Ch. 16.
Q3. A 28-year-old individual with a history of childhood emotional neglect and recurrent episodes of binge
eating followed by self-induced vomiting presents with significant distress. The individual reports feeling a
sense of loss of control during binges and uses vomiting to prevent weight gain. Which of the following
psychodynamic constructs is most central to understanding the etiology of this individual's symptoms?
A. Unresolved Oedipal complex leading to oral fixation and regression
B. Deficient mentalization capacity resulting in impaired affect regulation and reliance on bodily actions to
manage emotional states
C. Maladaptive schema of defectiveness/shame leading to compensatory perfectionism and overcontrol
D. Classical conditioning associating food with comfort due to early reinforcement
Correct Answer: B. Deficient mentalization capacity resulting in impaired affect regulation and reliance on
bodily actions to manage emotional states
Rationale: Mentalization-based theory posits that insecure attachment and early adversity impair the capacity to
understand one's own and others' mental states, leading to affect dysregulation. In bulimia nervosa, binge-purge
cycles serve as a non-mentalizing way to regulate intense emotions. Option A (Oedipal complex) is outdated and
not empirically supported for bulimia. Option C is more relevant to anorexia nervosa. Option D is a behavioral
explanation, not psychodynamic.
Why Wrong:
A - The Oedipal complex is a Freudian concept not empirically validated as an etiological factor in bulimia
nervosa.
C - Maladaptive schemas of defectiveness and overcontrol are more characteristic of anorexia nervosa, not
bulimia.
D - Classical conditioning is a behavioral mechanism, not a psychodynamic construct central to
understanding bulimia.
Reference: Bateman, A., & Fonagy, P. (2019). Handbook of Mentalizing in Mental Health Practice (2nd ed.).
American Psychiatric Association Publishing, Ch. 1.
Q4. A 45-year-old individual with a diagnosis of schizophrenia has been maintained on clozapine 400 mg
daily for the past 6 months with significant improvement in positive symptoms. However, the patient develops
new-onset hypersalivation, constipation, and sedation. The patient's white blood cell count remains within
normal limits. Which of the following is the most appropriate initial management for the hypersalivation?
A. Reduce clozapine dose to 300 mg daily
B. Add ipratropium bromide nasal spray 0.03% two sprays each nostril twice daily
C. Add prazosin 1 mg orally at bedtime
D. Add benztropine 1 mg orally twice daily
Correct Answer: B. Add ipratropium bromide nasal spray 0.03% two sprays each nostril twice daily
Rationale: Clozapine-induced hypersalivation is a common side effect thought due to muscarinic M4 receptor
agonism. Ipratropium bromide, an anticholinergic nasal spray, can be used to reduce salivation without systemic
anticholinergic effects. A dose reduction may compromise efficacy. Prazosin is for nightmares in PTSD.
Benztropine is an anticholinergic but its systemic effects may exacerbate constipation and sedation.
Why Wrong:
A - Reducing clozapine dose may lead to relapse of psychotic symptoms; it is not first-line for managing
hypersalivation.
C - Prazosin is indicated for PTSD-related nightmares, not for clozapine-induced hypersalivation.
D - Benztropine is an anticholinergic that can worsen constipation and sedation, and systemic effects are
undesirable.
Reference: Stahl, S. M. (2021). Stahl's Essential Psychopharmacology (5th ed.). Cambridge University Press, Ch.
5.
Page 4
Verified Questions
NSG527 Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation resource for NSG527 covers psychopathology, theories, and
advanced clinical modalities. It includes 250 verified questions and answers designed to help students
master key concepts and achieve a high score. The content is aligned with the latest Wilkes University
curriculum and evidence-based practices.
Key Features:
Psychopathology across the lifespan
Major theoretical frameworks (psychodynamic, cognitive-behavioral, humanistic, biological)
Advanced clinical modalities (CBT, DBT, EMDR, psychopharmacology)
Diagnostic criteria and differential diagnosis (DSM-5-TR)
Ethical and legal considerations in advanced practice
Integrated case studies and clinical reasoning
Updates for 2026:
- Updated to reflect DSM-5-TR diagnostic criteria
- Incorporated latest evidence-based treatment guidelines
- Added new questions on telehealth and cultural competence
- Revised rationales for clarity and accuracy
- Enhanced distractor explanations to address common misconceptions
Abstract:
This document provides a rigorous review of psychopathology, theoretical foundations, and advanced clinical
modalities essential for the NSG527 final exam. It synthesizes key concepts from major theoretical orientations,
including psychodynamic, cognitive-behavioral, humanistic, and biological perspectives, and applies them to the
assessment and treatment of mental disorders across the lifespan. The 250 verified questions are organized by
content area, with detailed rationales and distractor analyses to reinforce learning. Emphasis is placed on
differential diagnosis using DSM-5-TR criteria, evidence-based interventions, and ethical decision-making in
advanced practice nursing. This resource is designed to facilitate mastery of complex material and promote critical
thinking for clinical application.
Keywords:
NSG527, Psychopathology, Theories, Clinical Modalities, DSM-5-TR, Advanced Practice Nursing, Wilkes
University, Exam Prep
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining why it is correct. Incorrect
options are accompanied by distractor explanations that clarify common errors and reinforce key concepts.
Compliance Checklist:
Aligned with Wilkes University NSG527 curriculum
Based on DSM-5-TR diagnostic criteria
Incorporates current evidence-based practice guidelines
Includes ethical and legal standards for advanced practice
Covers lifespan and cultural considerations
Page 1
, Verified for accuracy by subject matter experts
Content Area Overview:
Content Area Questions Key Topics Weight
Foundations of Psychopathology 1-50 Historical perspectives, classification 20%
systems, epidemiology, etiology
Theoretical Frameworks 51-100 Psychodynamic, cognitive-behavioral, 20%
humanistic, biological, systems theory
Assessment and Diagnosis 101-150 Clinical interview, mental status exam, 20%
DSM-5-TR criteria, differential diagnosis
Advanced Clinical Modalities 151-200 CBT, DBT, EMDR, psychopharmacology, 20%
motivational interviewing
Special Populations and Ethical 201-250 Child/adolescent, geriatric, cultural 20%
Issues competence, legal/ethical dilemmas
Page 2
,Q1. A 34-year-old individual presents with a 6-month history of pervasive and excessive worry about
multiple life circumstances, accompanied by restlessness, muscle tension, sleep disturbance, and difficulty
concentrating. The individual reports that these symptoms have been present almost daily and are not
attributable to a substance or medical condition. Which of the following best describes the neurobiological
mechanism most implicated in the maintenance of this condition?
A. Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis leading to elevated cortisol and reduced
hippocampal volume
B. Dysregulation of the default mode network (DMN) with excessive connectivity between the prefrontal
cortex and amygdala
C. Impaired extinction of conditioned fear responses due to deficient ventromedial prefrontal cortex (vmPFC)
inhibition of the amygdala
D. Reduced gamma-aminobutyric acid (GABA)ergic tone in the basolateral amygdala and impaired
benzodiazepine receptor sensitivity
Correct Answer: D. Reduced gamma-aminobutyric acid (GABA)ergic tone in the basolateral amygdala and
impaired benzodiazepine receptor sensitivity
Rationale: Generalized anxiety disorder (GAD) is associated with reduced GABAergic inhibition in the amygdala
and other limbic structures, leading to heightened arousal and worry. Option A describes HPA axis hyperactivity
more characteristic of major depressive disorder. Option B describes DMN dysregulation seen in rumination but
not specific to GAD. Option C describes impaired fear extinction typical of PTSD, not the persistent worry of GAD.
Why Wrong:
A - HPA axis hyperactivity with elevated cortisol and hippocampal volume reduction is more characteristic of
major depressive disorder rather than generalized anxiety disorder.
B - Default mode network dysregulation is implicated in rumination and depression, not specifically in the
excessive worry of GAD.
C - Impaired fear extinction due to vmPFC-amygdala dysfunction is a hallmark of PTSD, not generalized
anxiety disorder.
Reference: Stahl, S. M. (2021). Stahl's Essential Psychopharmacology (5th ed.). Cambridge University Press, Ch.
8.
Q2. A patient with a history of recurrent major depressive episodes has not responded to adequate trials of
two different SSRIs and one SNRI. The patient is now being considered for augmentation with a
second-generation antipsychotic. Which of the following mechanisms best explains the efficacy of
aripiprazole in treatment-resistant depression?
A. Selective antagonism of 5-HT2A receptors leading to increased dopamine release in the prefrontal cortex
B. Partial agonism at D2 and 5-HT1A receptors combined with antagonism at 5-HT2A receptors
C. Potent inhibition of serotonin and norepinephrine reuptake with additional 5-HT2C antagonism
D. Full agonism at D1 receptors in the mesolimbic pathway enhancing reward processing
Correct Answer: B. Partial agonism at D2 and 5-HT1A receptors combined with antagonism at 5-HT2A
receptors
Rationale: Aripiprazole is a partial agonist at D2 and 5-HT1A receptors and an antagonist at 5-HT2A receptors.
This unique profile allows it to modulate dopaminergic and serotonergic transmission, improving depressive
symptoms without full blockade. Option A describes the mechanism of atypical antipsychotics like risperidone but
not aripiprazole. Option C describes the mechanism of vortioxetine, not aripiprazole. Option D is incorrect because
aripiprazole is not a full D1 agonist.
Why Wrong:
A - Selective 5-HT2A antagonism with increased prefrontal dopamine is characteristic of drugs like
risperidone, not aripiprazole.
C - Potent inhibition of serotonin and norepinephrine reuptake with 5-HT2C antagonism describes
vortioxetine, not aripiprazole.
D - Full D1 agonism is not a property of aripiprazole; it is a partial agonist at D2 receptors.
Page 3
, Reference: Lehne, R. A., & Rosenthal, L. (2022). Pharmacology for Nursing Care (11th ed.). Elsevier, Ch. 16.
Q3. A 28-year-old individual with a history of childhood emotional neglect and recurrent episodes of binge
eating followed by self-induced vomiting presents with significant distress. The individual reports feeling a
sense of loss of control during binges and uses vomiting to prevent weight gain. Which of the following
psychodynamic constructs is most central to understanding the etiology of this individual's symptoms?
A. Unresolved Oedipal complex leading to oral fixation and regression
B. Deficient mentalization capacity resulting in impaired affect regulation and reliance on bodily actions to
manage emotional states
C. Maladaptive schema of defectiveness/shame leading to compensatory perfectionism and overcontrol
D. Classical conditioning associating food with comfort due to early reinforcement
Correct Answer: B. Deficient mentalization capacity resulting in impaired affect regulation and reliance on
bodily actions to manage emotional states
Rationale: Mentalization-based theory posits that insecure attachment and early adversity impair the capacity to
understand one's own and others' mental states, leading to affect dysregulation. In bulimia nervosa, binge-purge
cycles serve as a non-mentalizing way to regulate intense emotions. Option A (Oedipal complex) is outdated and
not empirically supported for bulimia. Option C is more relevant to anorexia nervosa. Option D is a behavioral
explanation, not psychodynamic.
Why Wrong:
A - The Oedipal complex is a Freudian concept not empirically validated as an etiological factor in bulimia
nervosa.
C - Maladaptive schemas of defectiveness and overcontrol are more characteristic of anorexia nervosa, not
bulimia.
D - Classical conditioning is a behavioral mechanism, not a psychodynamic construct central to
understanding bulimia.
Reference: Bateman, A., & Fonagy, P. (2019). Handbook of Mentalizing in Mental Health Practice (2nd ed.).
American Psychiatric Association Publishing, Ch. 1.
Q4. A 45-year-old individual with a diagnosis of schizophrenia has been maintained on clozapine 400 mg
daily for the past 6 months with significant improvement in positive symptoms. However, the patient develops
new-onset hypersalivation, constipation, and sedation. The patient's white blood cell count remains within
normal limits. Which of the following is the most appropriate initial management for the hypersalivation?
A. Reduce clozapine dose to 300 mg daily
B. Add ipratropium bromide nasal spray 0.03% two sprays each nostril twice daily
C. Add prazosin 1 mg orally at bedtime
D. Add benztropine 1 mg orally twice daily
Correct Answer: B. Add ipratropium bromide nasal spray 0.03% two sprays each nostril twice daily
Rationale: Clozapine-induced hypersalivation is a common side effect thought due to muscarinic M4 receptor
agonism. Ipratropium bromide, an anticholinergic nasal spray, can be used to reduce salivation without systemic
anticholinergic effects. A dose reduction may compromise efficacy. Prazosin is for nightmares in PTSD.
Benztropine is an anticholinergic but its systemic effects may exacerbate constipation and sedation.
Why Wrong:
A - Reducing clozapine dose may lead to relapse of psychotic symptoms; it is not first-line for managing
hypersalivation.
C - Prazosin is indicated for PTSD-related nightmares, not for clozapine-induced hypersalivation.
D - Benztropine is an anticholinergic that can worsen constipation and sedation, and systemic effects are
undesirable.
Reference: Stahl, S. M. (2021). Stahl's Essential Psychopharmacology (5th ed.). Cambridge University Press, Ch.
5.
Page 4
